John Michael Taylor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
John Michael Taylor has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
Sudhakar Vadivelu
University of Cincinnati, College of Medicine, Cincinnati, Ohio; Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Division of Neurosurgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
4 shared publicationsBin Zhang
University of Cincinnati, College of Medicine, Cincinnati, Ohio; Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
3 shared publicationsJames L. Leach
University of Cincinnati, College of Medicine, Cincinnati, Ohio; Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
3 shared publicationsAlan M. Chen
Radiology Associates of Tallahassee, Tallahassee, Florida
2 shared publicationsAndrew Furthmiller
Department of Radiology and
2 shared publicationsKunal B. Karani
Department of Radiology and
2 shared publications
Latest Publications
- Open Access
- 15 November 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (11) , 1249
Genetic Evaluation of Intracranial Arterial Aneurysms in Pediatric Practice: A Pragmatic Approach for the Clinician
Intracranial arterial aneurysm (IAA) is an important cause of hemorrhagic stroke in children and presents a unique diagnostic challenge for the clinician. Exhibiting failure of arterial wall integrity decades before the general population, this early and aggressive arteriopathy suggests intrinsic susceptibility to disease. This narrative review summarizes the literature on IAA genetics, highlighting monogenetic causes, known risk alleles from population-based analyses, and opportunities to expand the literature on childhood disease. Clinical findings that may lead to suspicion for genetic arteriopathy are discussed—highlighting connective tissue disorder phenotypes, family history of arteriopathy, and radiographic characteristics unique to childhood IAA. The common clinical genetic diagnostics—targeted gene panels, whole exome sequencing, whole genome sequencing, and advanced testing modalities—are detailed with attention to their use in IAA in children and adults. Given the ever-expanding palette of genetic testing platforms, the busy clinician may find test selection daunting and access to genetic professionals rare. To help with this selection, we provide a pragmatic guide to test selection and analysis of genetic testing in childhood IAA.
- 15 November 2026
- Published by MDPI AG in Brain Sciences
- Vol. 16 (11) , 1249
Open AccessGenetic Evaluation of Intracranial Arterial Aneurysms in Pediatric Practice: A Pragmatic Approach for the Clinician
Intracranial arterial aneurysm (IAA) is an important cause of hemorrhagic stroke in children and presents a unique diagnostic challenge for the clinician. Exhibiting failure of arterial wall integrity decades before the general population, this early and aggressive arteriopathy suggests intrinsic susceptibility to disease. This narrative review summarizes the literature on IAA genetics, highlighting monogenetic causes, known risk alleles from population-based analyses, and opportunities to expand the literature on childhood disease. Clinical findings that may lead to suspicion for genetic arteriopathy are discussed—highlighting connective tissue disorder phenotypes, family history of arteriopathy, and radiographic characteristics unique to childhood IAA. The common clinical genetic diagnostics—targeted gene panels, whole exome sequencing, whole genome sequencing, and advanced testing modalities—are detailed with attention to their use in IAA in children and adults. Given the ever-expanding palette of genetic testing platforms, the busy clinician may find test selection daunting and access to genetic professionals rare. To help with this selection, we provide a pragmatic guide to test selection and analysis of genetic testing in childhood IAA.
- Top Cited PapersOpen Access
- 21 May 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 98 (1) , 3-22
Guidelines for the Diagnosis and Clinical Management of Cavernous Malformations of the Brain and Spinal Cord: Consensus Recommendations Based on a Systematic Literature Review by the Alliance to Cure Cavernous Malformation Clinical Advisory Board Experts Panel
BACKGROUND AND OBJECTIVES: Despite many publications about cavernous malformations (CMs), controversy remains regarding diagnostic and management strategies. To update evidence-based guidelines for the clinical management of brain and spinal cord CMs. METHODS: The Alliance to Cure CMs, the patient support group in the United States advocating on behalf of patients and research in CM, convened a multidisciplinary writing group comprising expert CM clinicians to help summarize the existing literature related to the clinical care of CM, focusing on 5 topics: (1) epidemiology and natural history, (2) genetic testing and counseling, (3) diagnostic criteria and imaging standards, (4) neurosurgical considerations, and (5) neurological considerations. Building on prior evidence-based recommendations reflecting literature review through October 2014, the group conducted a systematic review of the more recent literature, identified references for mandatory citation, rated evidence, developed recommendations, and established consensus according to a prespecified protocol. Finally, the writing group outlined remaining knowledge gaps and controversies to guide future research. RESULTS: From 2672 publications published between October 1, 2014, and March 15, 2023, and meeting key word criteria, 234 were selected based on prearticulated criteria for mandatory consideration in evidence-based recommendations. Topic authors used these and other supporting references to summarize current knowledge and arrive at 53 management recommendations, with unanimous consensus based on a Delphi process. These were rated by class (strength of recommendation) and level (quality of evidence) per the American Heart Association/American Stroke Association criteria. Eighteen recommendations were class 1 (34%), class 2 in 31 (58%), and class 3 in 4 (8%). Three were level A (6%), 19 (36%) were level B, and 31 (58%) were level C. CONCLUSION: Current evidence supports prior and new recommendations for the management of CMs, but many reflect moderate classes and low levels, mandating further research to better inform clinical practice.
- 21 May 2025
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 98 (1) , 3-22
Top Cited PapersOpen AccessGuidelines for the Diagnosis and Clinical Management of Cavernous Malformations of the Brain and Spinal Cord: Consensus Recommendations Based on a Systematic Literature Review by the Alliance to Cure Cavernous Malformation Clinical Advisory Board Experts Panel
BACKGROUND AND OBJECTIVES: Despite many publications about cavernous malformations (CMs), controversy remains regarding diagnostic and management strategies. To update evidence-based guidelines for the clinical management of brain and spinal cord CMs. METHODS: The Alliance to Cure CMs, the patient support group in the United States advocating on behalf of patients and research in CM, convened a multidisciplinary writing group comprising expert CM clinicians to help summarize the existing literature related to the clinical care of CM, focusing on 5 topics: (1) epidemiology and natural history, (2) genetic testing and counseling, (3) diagnostic criteria and imaging standards, (4) neurosurgical considerations, and (5) neurological considerations. Building on prior evidence-based recommendations reflecting literature review through October 2014, the group conducted a systematic review of the more recent literature, identified references for mandatory citation, rated evidence, developed recommendations, and established consensus according to a prespecified protocol. Finally, the writing group outlined remaining knowledge gaps and controversies to guide future research. RESULTS: From 2672 publications published between October 1, 2014, and March 15, 2023, and meeting key word criteria, 234 were selected based on prearticulated criteria for mandatory consideration in evidence-based recommendations. Topic authors used these and other supporting references to summarize current knowledge and arrive at 53 management recommendations, with unanimous consensus based on a Delphi process. These were rated by class (strength of recommendation) and level (quality of evidence) per the American Heart Association/American Stroke Association criteria. Eighteen recommendations were class 1 (34%), class 2 in 31 (58%), and class 3 in 4 (8%). Three were level A (6%), 19 (36%) were level B, and 31 (58%) were level C. CONCLUSION: Current evidence supports prior and new recommendations for the management of CMs, but many reflect moderate classes and low levels, mandating further research to better inform clinical practice.
- 6 June 2023
- Published by Wolters Kluwer Health in Neurology
- Vol. 100 (23) , 1077-1078
The Role of Hereditary Hemorrhagic Telangiectasia in Neurologic Practice
- 6 June 2023
- Published by Wolters Kluwer Health in Neurology
- Vol. 100 (23) , 1077-1078
The Role of Hereditary Hemorrhagic Telangiectasia in Neurologic Practice
- Open Access
- 30 December 2022
- Published by Pediatric Neurology Briefs Publishers in Pediatric Neurology Briefs
- Vol. 36
Differentiation of Posterior and Anterior Ischemic Stroke
- 30 December 2022
- Published by Pediatric Neurology Briefs Publishers in Pediatric Neurology Briefs
- Vol. 36
Open AccessDifferentiation of Posterior and Anterior Ischemic Stroke
- 24 June 2022
- Published by Elsevier in Pediatric Neurology
- Vol. 134, 59-66
Cerebral Arterial Growth in Childhood
- 24 June 2022
- Published by Elsevier in Pediatric Neurology
- Vol. 134, 59-66
Cerebral Arterial Growth in Childhood
- 1 October 2019
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of neurosurgery. Pediatrics
- Vol. 24 (4) , 389-396
Cervicocerebral quantitative arterial tortuosity: a biomarker of arteriopathy in children with intracranial aneurysms
OBJECTIVE: Although intracranial arterial aneurysms (IAAs) of childhood are usually idiopathic, it is possible that underlying arteriopathy escapes detection when using conventional diagnostic tools. Quantitative arterial tortuosity (QAT) has been studied as a biomarker of arteriopathy. The authors analyzed cervicocerebral QAT in children with idiopathic IAAs to assess the possibility of arteriopathy.METHODS: Cases were identified by text-string searches of imaging reports spanning the period January 1993 through June 2017. QAT of cervicocerebral arterial segments was measured from cross-sectional studies using image-processing software. Other imaging and clinical data were confirmed by retrospective electronic record review. Children with idiopathic IAAs and positive case controls, with congenital arteriopathy differentiated according to aneurysm status (with and without an aneurysm), were compared to each other and to healthy controls without vascular risk factors.RESULTS: Cervicocerebral QAT was measured in 314 children: 24 with idiopathic IAAs, 163 with congenital arteriopathy (including 14 arteriopathic IAAs), and 127 healthy controls. QAT of all vertebrobasilar segments was larger in children with IAAs (idiopathic and arteriopathic forms) (p < 0.05). In children with congenital arteriopathy without an aneurysm, QAT was decreased for the distal cervical vertebral arteries and increased for the supraspinal vertebral artery relative to healthy children. QAT of specific cervicocerebral segments correlated with IAA size and rupture status.CONCLUSIONS: Cervicocerebral QAT is a biomarker of arteriopathy in children with IAA, even in the absence of other disease markers. Additional findings suggest a correlation of cervicocerebral QAT with IAA size and rupture status and with the presence of IAA in children with congenital arteriopathy.
- 1 October 2019
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of neurosurgery. Pediatrics
- Vol. 24 (4) , 389-396
Cervicocerebral quantitative arterial tortuosity: a biomarker of arteriopathy in children with intracranial aneurysms
OBJECTIVE: Although intracranial arterial aneurysms (IAAs) of childhood are usually idiopathic, it is possible that underlying arteriopathy escapes detection when using conventional diagnostic tools. Quantitative arterial tortuosity (QAT) has been studied as a biomarker of arteriopathy. The authors analyzed cervicocerebral QAT in children with idiopathic IAAs to assess the possibility of arteriopathy.METHODS: Cases were identified by text-string searches of imaging reports spanning the period January 1993 through June 2017. QAT of cervicocerebral arterial segments was measured from cross-sectional studies using image-processing software. Other imaging and clinical data were confirmed by retrospective electronic record review. Children with idiopathic IAAs and positive case controls, with congenital arteriopathy differentiated according to aneurysm status (with and without an aneurysm), were compared to each other and to healthy controls without vascular risk factors.RESULTS: Cervicocerebral QAT was measured in 314 children: 24 with idiopathic IAAs, 163 with congenital arteriopathy (including 14 arteriopathic IAAs), and 127 healthy controls. QAT of all vertebrobasilar segments was larger in children with IAAs (idiopathic and arteriopathic forms) (p < 0.05). In children with congenital arteriopathy without an aneurysm, QAT was decreased for the distal cervical vertebral arteries and increased for the supraspinal vertebral artery relative to healthy children. QAT of specific cervicocerebral segments correlated with IAA size and rupture status.CONCLUSIONS: Cervicocerebral QAT is a biomarker of arteriopathy in children with IAA, even in the absence of other disease markers. Additional findings suggest a correlation of cervicocerebral QAT with IAA size and rupture status and with the presence of IAA in children with congenital arteriopathy.
- 16 May 2019
- Published by Wiley in American Journal of Hematology
- Vol. 94 (8) , 949-954
Hemoglobin Southampton complicated by cerebral ischemia, moyamoya, and hydroxyurea‐induced methemoglobinemia
- 16 May 2019
- Published by Wiley in American Journal of Hematology
- Vol. 94 (8) , 949-954
Hemoglobin Southampton complicated by cerebral ischemia, moyamoya, and hydroxyurea‐induced methemoglobinemia
- 1 April 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (4) , 1011-1014
Quantitative Arterial Tortuosity Suggests Arteriopathy in Children With Cryptogenic Stroke
Background and Purpose—: Quantitative arterial tortuosity (QAT) is a ratio of vessel length between 2 points to the shortest linear distance between same points. QAT has been reported as an imaging biomarker of arteriopathy in pediatric arterial ischemic stroke (AIS) because of dissection and transient cerebral arteriopathy. We sought to determine whether QAT abnormalities are present in other subtypes of pediatric AIS. Methods—: Children with AIS-absent conventional biomarkers of arteriopathy and case–controls who underwent magnetic resonance angiography were classified by stroke mechanism. The primary study population consisted of cryptogenic AIS cases. AIS with bow hunter physiology and cardiogenic emboli were also evaluated. AIS because of nontraumatic dissection served as positive controls. Patients without vascular risk factors served as negative controls. Segmental QAT of cervicocerebral arteries were measured using automated image processing and differences between groups analyzed. Results—: In negative controls, QAT showed significant age-related variability for most arterial segments. Positive controls showed significantly increased QAT of the distal extracranial vertebral arteries (VAs) and decreased QAT of the intracranial VA relative to negative controls. Cryptogenic stroke and bow hunter physiology cases were similar to positive controls showing increased QAT of the distal extracranial VA and decreased QAT of the intracranial VA relative to negative controls. Cardioembolic stroke cases were similar to negative controls showing decreased QAT of the distal extracranial VA and increased QAT of the intracranial VA relative to positive controls. Conclusions—: Pediatric cryptogenic stroke is frequently associated with cervicocerebral arteriopathies expressing altered QAT. QAT may be a diagnostic biomarker of arteriopathy in pediatric AIS.
- 1 April 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (4) , 1011-1014
Quantitative Arterial Tortuosity Suggests Arteriopathy in Children With Cryptogenic Stroke
Background and Purpose—: Quantitative arterial tortuosity (QAT) is a ratio of vessel length between 2 points to the shortest linear distance between same points. QAT has been reported as an imaging biomarker of arteriopathy in pediatric arterial ischemic stroke (AIS) because of dissection and transient cerebral arteriopathy. We sought to determine whether QAT abnormalities are present in other subtypes of pediatric AIS. Methods—: Children with AIS-absent conventional biomarkers of arteriopathy and case–controls who underwent magnetic resonance angiography were classified by stroke mechanism. The primary study population consisted of cryptogenic AIS cases. AIS with bow hunter physiology and cardiogenic emboli were also evaluated. AIS because of nontraumatic dissection served as positive controls. Patients without vascular risk factors served as negative controls. Segmental QAT of cervicocerebral arteries were measured using automated image processing and differences between groups analyzed. Results—: In negative controls, QAT showed significant age-related variability for most arterial segments. Positive controls showed significantly increased QAT of the distal extracranial vertebral arteries (VAs) and decreased QAT of the intracranial VA relative to negative controls. Cryptogenic stroke and bow hunter physiology cases were similar to positive controls showing increased QAT of the distal extracranial VA and decreased QAT of the intracranial VA relative to negative controls. Cardioembolic stroke cases were similar to negative controls showing decreased QAT of the distal extracranial VA and increased QAT of the intracranial VA relative to positive controls. Conclusions—: Pediatric cryptogenic stroke is frequently associated with cervicocerebral arteriopathies expressing altered QAT. QAT may be a diagnostic biomarker of arteriopathy in pediatric AIS.